Dr. Wong Discusses Monoclonal Antibodies in Plasma Cell Neoplasms

Sandy Wong, MD
Published: Tuesday, Oct 10, 2017



Sandy Wong, MD, assistant professor, Division of Hematology/Oncology, UCSF School of Medicine, discusses monoclonal antibodies in plasma cell neoplasms.

NEOD001 is an anti-amyloid fibril monoclonal antibody that augments the macrophage system in order to clear away amyloid fibrils from the organs.

This investigational agent is currently awaiting phase II and III trial results, but the signs of efficacy are promising, says Wong.
 


Sandy Wong, MD, assistant professor, Division of Hematology/Oncology, UCSF School of Medicine, discusses monoclonal antibodies in plasma cell neoplasms.

NEOD001 is an anti-amyloid fibril monoclonal antibody that augments the macrophage system in order to clear away amyloid fibrils from the organs.

This investigational agent is currently awaiting phase II and III trial results, but the signs of efficacy are promising, says Wong.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions and New Answers to Optimize OutcomesOct 31, 20182.0
Hematology Briefings™: Advancing Care and Improving Outcomes for Patients With Pyruvate Kinase DeficiencyOct 31, 20181.0
Publication Bottom Border
Border Publication
x